Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options. (Q34643529)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Peter S Maclean

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

1429-1440

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.2165/00003495-200767100-00005

1 January 2020

exact match

0 references

cites work

A surprising new protein superfamily containing ovalbumin, antithrombin-III, and alpha 1-proteinase inhibitor

1 reference

12 December 2020

Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation

1 reference

12 December 2020

Safety of antithrombin III concentrate

1 reference

12 December 2020

Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin

1 reference

12 December 2020

Inherited fibrinogen abnormality causing thrombophilia

1 reference

12 December 2020

Recurrence rate after a first venous thrombosis in patients with familial thrombophilia

1 reference

12 December 2020

Congenital antithrombin III deficiency. Incidence and clinical features

1 reference

12 December 2020

Inherited thrombophilia: pathogenesis, clinical syndromes, and management.

1 reference

12 December 2020

Management of thrombophilia

1 reference

12 December 2020

Thrombophilia in pregnancy: a systematic review

1 reference

12 December 2020

Postoperative antithrombin levels and outcome in cardiac operations.

1 reference

12 December 2020

Investigation and management of heritable thrombophilia

1 reference

12 December 2020

Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial

1 reference

12 December 2020

Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.

1 reference

12 December 2020

Prevalence of antithrombin deficiency in the healthy population.

1 reference

12 December 2020

Antithrombin III concentrates--are they clinically useful?

1 reference

12 December 2020

The suprapharmacologic dosing of antithrombin concentrate for Staphylococcus aureus-induced disseminated intravascular coagulation in guinea pigs: substantial reduction in mortality and morbidity.

1 reference

12 December 2020

The anti-inflammatory actions of antithrombin--a review

1 reference

12 December 2020

Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy

1 reference

12 December 2020

Recombinant human transgenic antithrombin in cardiac surgery: a dose-finding study

1 reference

12 December 2020

Evaluation of the safety, recovery, half-life, and clinical efficacy of antithrombin III (human) in patients with hereditary antithrombin III deficiency. Cooperative Study Group

1 reference

12 December 2020

Changes in antithrombin activity and platelet counts in the late stage of twin and triplet pregnancies

1 reference

12 December 2020

Thrombosis in antithrombin-III-deficient persons. Report of a large kindred and literature review

1 reference

12 December 2020

Commercial antithrombin concentrate contains inactive L-forms of antithrombin.

1 reference

12 December 2020

Can the administration of antithrombin III decrease the risk of cerebral hemorrhage in premature infants?

1 reference

12 December 2020

Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy.

1 reference

12 December 2020

The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study.

1 reference

12 December 2020

Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery

1 reference

12 December 2020

Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy

1 reference

12 December 2020

Antithrombin supplementation III in childhood acute lymphoblastic leukemia treated with L-asparaginase

1 reference

12 December 2020

Pharmacokinetics of recombinant transgenic antithrombin in volunteers

1 reference

12 December 2020

A placebo-controlled randomized trial of antithrombin therapy in neonatal respiratory distress syndrome

1 reference

12 December 2020

Antithrombin deficiency: issues in laboratory diagnosis

1 reference

12 December 2020

Antithrombin can modulate coagulation, cytokine production, and expression of adhesion molecules in abdominal aortic aneurysm repair surgery

1 reference

12 December 2020

Thrombin generation and its inhibition: a review of the scientific basis and mechanism of action of anticoagulant therapies

1 reference

12 December 2020

Impact of antithrombin deficiency in thrombogenesis: lipopolysaccharide and stress-induced thrombus formation in heterozygous antithrombin-deficient mice

1 reference

12 December 2020

Mortality and causes of death in inherited antithrombin deficiency.

1 reference

12 December 2020

Acquired antithrombin deficiency in sepsis

1 reference

12 December 2020

Clotting inhibitors and fibronectin as potential markers in preeclampsia

1 reference

12 December 2020

Influence of demographic factors on antithrombin III activity in a healthy population

1 reference

12 December 2020

High-dose antithrombin III in the treatment of severe sepsis in patients with a high risk of death: efficacy and safety

1 reference

12 December 2020

Increased fetal loss in women with heritable thrombophilia.

1 reference

12 December 2020

Molecular genetics of antithrombin deficiency

1 reference

12 December 2020

Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha

1 reference

12 December 2020

Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin.

1 reference

12 December 2020

Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures.

1 reference

12 December 2020

Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.

1 reference

12 December 2020

Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism--results of the Spanish Multicentric Study on Thrombophilia (EMET-Study)

1 reference

12 December 2020

Factors associated with excessive postoperative blood loss and hemostatic transfusion requirements: a multivariate analysis in cardiac surgical patients.

1 reference

12 December 2020

Antithrombin: its physiological importance and role in DIC.

1 reference

12 December 2020

Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli

1 reference

12 December 2020

Risk factors for pregnancy associated venous thromboembolism

1 reference

12 December 2020

A randomized trial of antithrombin concentrate for treatment of heparin resistance.

1 reference

12 December 2020

The incidence of venous thromboembolism in thrombophilic children: a prospective cohort study

1 reference

12 December 2020

Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy

1 reference

12 December 2020

Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families

1 reference

12 December 2020

Thrombophilia: implications for pregnancy outcome

1 reference

12 December 2020

Determinants of antithrombin consumption in cardiac operations requiring cardiopulmonary bypass

1 reference

12 December 2020

Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass.

1 reference

12 December 2020

Relationship between coagulation cascade, cytokine, adhesion molecule and aortic aneurysm

1 reference

12 December 2020

Insight into the mechanism of asparaginase-induced depletion of antithrombin III in treatment of childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Antithrombotic therapies for sepsis: a need for more studies

1 reference

12 December 2020

Thrombophilias and recurrent pregnancy loss: a critical appraisal of the literature

1 reference

12 December 2020

Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: review of 404 cases

1 reference

12 December 2020

Low thrombosis rate seen in blood donors and their relatives with inherited deficiencies of antithrombin and protein C: correlation with type of defect, family history, and absence of the factor V Leiden mutation

1 reference

12 December 2020

Evaluation of natural coagulation inhibitor levels in various hypertensive states of pregnancy.

1 reference

12 December 2020

The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease

1 reference

12 December 2020

Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study

1 reference

12 December 2020

Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis

1 reference

12 December 2020

Actions and Interactions of Antithrombin and Heparin

1 reference

12 December 2020

Low-molecular-weight heparin for the prevention and treatment of venous thromboembolism in pregnancy

1 reference

12 December 2020

Inherited thrombophilia

1 reference

12 December 2020

10.2165/00003495-200767100-00005

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 January 2020

1031349092

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17600391%20AND%20SRC:MED&resulttype=core&format=json